Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P860004/S465

SynchroMed Infusion System, Ascenda Intrathecal Catheters

Medtronic, Inc. · Decision date Oct 30, 2026

MEDTECHLEDGER EXPLANATIONP860004/S465

What did the FDA decide?

FDA lists this as supplement P860004/S465 to the SynchroMed Infusion System, Ascenda Intrathecal Catheters PMA. The decision is a 30-Day Notice for a process change, so the record describes manufacturing changes tied to the existing approved system rather than a new approval of the whole device.

The specific changes are a new surface mount technology production line, a revised SMT process sequence with automated optical inspection after each SMT assembly stage, and added solder paste inspection plus a qualified de-paneling machine for PCBA production. The source does not provide clinical data, a new indication, or device performance results; it only states the manufacturing scope of the notice.

FDA approval order statement

approval for the following three changes: 1) Adding a new surface mount technology (SMT) production line.2) Revision of the SMT manufacturing process sequence to perform automated optical inspection immediately following each SMT assembly stage.3) Addition of an equivalent solder paste inspection system and addition of a qualified de-paneling machine for PCBA production
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
General Hospital
Decision date
Oct 30, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P860004/S465
Regulatory pathway
PMA supplement
Product code
LKK
Decision code
OK30
Decision date
Oct 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pump, infusion, implanted, programmable.

Product code
LKK
FDA device class
3

For the original device and its historical approval scope, see PMA P860004. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P860004 · Original PMA

    MEDTRONIC(R) SYNCHROMED(TM) PUMP & INFUSION SYSTEM

  2. P860004/S465 received

    Application receipt date recorded by FDA.

  3. P860004/S462 · Related supplement

    SynchroMed Infusion System, Ascenda Intrathecal Catheters

  4. P860004/S458 · Related supplement

    SynchroMed Infusion System, Ascenda Intrathecal Catheters

  5. P860004/S464 · Related supplement

    SynchroMed Infusion System, Ascenda Intrathecal Catheters TDD (Drug Delivery Infusion Pump 8667), TDD (Drug Delivery I

  6. P860004/S465 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P860004. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P860004

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records